Prevest DenPro reported a 13.9% year-on-year revenue increase to ₹71.81 crore for FY 2025-26. Profit after tax stood at ₹20.49 crore. The company saw strong growth in digital dentistry, offsetting a decline in its Oradox business due to export hurdles.
Prevest DenPro Reports Strong FY26 Performance Amidst Global Challenges
Prevest DenPro's revenue for FY 2025-26 reached ₹71.81 crore, a 13.9% increase from ₹63.03 crore in the previous fiscal year. Profit after tax (PAT) for the year was ₹20.49 crore.
Reader Takeaway: Digital dentistry growth outpaces Oradox dip; watch OEM expansion and export recovery.
What just happened
Prevest DenPro announced its financial results for the fiscal year ending March 31, 2026. The company posted revenue from operations of ₹71.81 crore, marking a 13.9% year-on-year growth. Profit after tax (PAT) for the fiscal year stood at ₹20.49 crore. Key profitability metrics include EBITDA at ₹29.62 crore and Profit Before Tax (PBT) at ₹27.61 crore, resulting in an EBITDA margin of 38.6% and a PAT margin of 26.7%.
Why this matters
The company's revenue growth indicates sustained demand for its products, even in a challenging global economic climate. The strong PAT and healthy margins suggest efficient operations and pricing power. The performance highlights the company's strategic focus on high-growth segments like digital dentistry, which saw significant increases in 3D printing resin sales (40.5%) and 3D printer sales (162%).
The backstory
Prevest DenPro operates in the dental materials and equipment sector. Its business segments include Digital Dentistry and the Oradox Business. The company has been focusing on expanding its domestic reach and international presence, including in the US and UAE. It also engages in Original Equipment Manufacturer (OEM) partnerships.
What changes now
The company plans to further expand its domestic footprint in Tier 2 and Tier 3 cities. Internationally, it will continue to leverage its US and UAE subsidiaries. A strategic goal is to add two more OEM partners within the next two years, adding to its existing 3-4 partnerships. The company is also investing in R&D for import substitution, aiming for indigenous 3D printer production by 2028.
Risks to watch
Management cited geopolitical conflicts in the Middle East impacting export dispatches and business activity. Additionally, new regulatory requirements in the US concerning cosmetic regulations created temporary export barriers for the Oradox business, which saw a 2% decline. These factors pose a short-term risk to international sales.
Peer comparison
While specific peer data for FY26 is not provided in the filing, Prevest DenPro's focus on digital dentistry aligns with broader industry trends. Companies in the dental technology space often see growth driven by innovation in 3D printing and digital workflows.
Context metrics (time-bound)
- FY 2025-26 Revenue: ₹71.81 crore (up 13.9% YoY)
- FY 2025-26 PAT: ₹20.49 crore
- 3D printing resins revenue: up 40.5% YoY
- 3D printers sales: up 162% YoY
- Oradox Business revenue: down 2% YoY
- OEM Partnerships: Currently 3-4, with plans to add two more in two years.
What to track next
Investors will be keen to observe the recovery of the Oradox business from US regulatory changes and Middle East disruptions. The expansion of OEM partnerships and progress on indigenous 3D printer development will be key indicators of future growth and diversification.